Lawmakers, Officials Again Question CIRM’s Activities
A new bill (SB 1064), by Sen. Elaine Alquist (D-Santa Clara), Â is the latest move by lawmakers to gain tighter control over the California Institute of Regenerative Medicine and ensure the state benefits from the agency's use of state funds. Lawmakers and other state officials have expressed concern about the potential for conflicts of interest related to grant distribution and a lack of openness about the agency's activities.
- "Stem Cell Agency Draws Capitol Scrutiny -- Again" (Howard, Capitol Weekly, 3/18).